KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBT (2016 - 2025)

Historic EBT for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $389.9 million.

  • Incyte's EBT rose 2429.43% to $389.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year increase of 42567.7%. This contributed to the annual value of $1.7 billion for FY2025, which is 42567.7% up from last year.
  • Latest data reveals that Incyte reported EBT of $389.9 million as of Q4 2025, which was up 2429.43% from $482.3 million recorded in Q3 2025.
  • In the past 5 years, Incyte's EBT registered a high of $558.0 million during Q2 2025, and its lowest value of -$389.8 million during Q2 2024.
  • In the last 5 years, Incyte's EBT had a median value of $219.4 million in 2021 and averaged $195.7 million.
  • As far as peak fluctuations go, Incyte's EBT skyrocketed by 607118.02% in 2021, and later tumbled by 24040.76% in 2024.
  • Quarter analysis of 5 years shows Incyte's EBT stood at $120.0 million in 2021, then crashed by 32.83% to $80.6 million in 2022, then skyrocketed by 236.11% to $271.0 million in 2023, then grew by 15.78% to $313.7 million in 2024, then rose by 24.29% to $389.9 million in 2025.
  • Its EBT stands at $389.9 million for Q4 2025, versus $482.3 million for Q3 2025 and $558.0 million for Q2 2025.